JAMA 2 Nov 2011 Vol 306 1874 The older you get, the more likely you are to have a haematological malignancy, and the less likely you are to be able to stand up to the rigours of myeloablative therapy followed by allogeneic haematopoietic cell transplantation, which can offer a cure in younger patients. You might […]
Richard Lehman’s journal review – 7 November 2011